2-201491843-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001168221.2(C2CD6):āc.4498C>Gā(p.Gln1500Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000332 in 1,384,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001168221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD6 | NM_001168221.2 | c.4498C>G | p.Gln1500Glu | missense_variant | 15/16 | ENST00000439140.6 | NP_001161693.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD6 | ENST00000439140.6 | c.4498C>G | p.Gln1500Glu | missense_variant | 15/16 | 1 | NM_001168221.2 | ENSP00000409937.1 | ||
C2CD6 | ENST00000286195.7 | c.1582-3941C>G | intron_variant | 1 | ENSP00000286195.3 | |||||
C2CD6 | ENST00000439802.5 | c.*50-3941C>G | intron_variant | 2 | ENSP00000400672.1 | |||||
C2CD6 | ENST00000482942.1 | n.101-3941C>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000705 AC: 1AN: 141806Hom.: 0 AF XY: 0.0000132 AC XY: 1AN XY: 75880
GnomAD4 exome AF: 0.0000332 AC: 46AN: 1384688Hom.: 0 Cov.: 33 AF XY: 0.0000337 AC XY: 23AN XY: 683268
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.4498C>G (p.Q1500E) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a C to G substitution at nucleotide position 4498, causing the glutamine (Q) at amino acid position 1500 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at